Better survival of renal cell carcinoma in patients with inflammatory bowel disease

Author(s):
Derikx, L.A.A.P.; Nissen, L.H.C.; Drenth, J.P.H.; Herpen, C.M. van; Kievit, W.; Verhoeven, R.H.A.; Mulders, P.F.A.; Hulsbergen-van de Kaa, C.A.; Boers-Sonderen, M.J.; Heuvel, T.R.A. van den; Pierik, M.; Nagtegaal, I.D.; Hoentjen, F.; Dutch Initiative Crohn Colitis ICC; PALGA Grp; IBD RCC Grp
Published
2015
Publication type
Article / Letter to editor
inflammatory bowel diseaserenal cell carcinomaimmunosuppressive therapy
Date issued
2015-11-10
Language
English
Is part of
Oncotarget (2015), Vol. 6, no. 35, p. 38336-38347
hdl
1887/117337